Elaborative encoding

Pivot Interactives Launches Top Five Webinars for Science Educators

Retrieved on: 
Tuesday, July 5, 2022

MINNEAPOLIS, July 05, 2022 (GLOBE NEWSWIRE) -- Pivot Interactives, a phenomena-based, active learning tool for science teaching, announces five free science webinars for science and STEM educators.

Key Points: 
  • MINNEAPOLIS, July 05, 2022 (GLOBE NEWSWIRE) -- Pivot Interactives, a phenomena-based, active learning tool for science teaching, announces five free science webinars for science and STEM educators.
  • Topics covered include Three-Dimensional Learning, Equity in Science, 5Es with Pivot Interactives, Learner Independence, and Seeing Science in a New Light.
  • Iris from Pivot Interactives can be used for videos both from the Pivot Interactives collection as well as an instructor- and student-uploaded videos.
  • Pivot Interactives, an award-winning platform, continues to innovate to revolutionize science education because science has the power to change lives.

Savvas Learning Company's Experience Physics Program Wins Tech & Learning Best of 2021 Award

Retrieved on: 
Tuesday, February 8, 2022

PARAMUS,N.J., Feb. 8, 2022 /PRNewswire/ -- Savvas Learning Company , a K-12 next-generation learning solutions leader, is proud to announce that its Experience Physics high school program has been named a winner of the Tech & Learning Awards of Excellence Best of 2021.

Key Points: 
  • PARAMUS,N.J., Feb. 8, 2022 /PRNewswire/ -- Savvas Learning Company , a K-12 next-generation learning solutions leader, is proud to announce that its Experience Physics high school program has been named a winner of the Tech & Learning Awards of Excellence Best of 2021.
  • The Tech & Learning Awards of Excellence Best of 2021 contest focused on "outstanding products" for supporting teaching and learning no matter the learning environment.
  • "We are honored that Tech & Learning has recognized Experience Physics as an exceptional product that offers students compelling activities with interactive technology to make learning physics engaging and fun."
  • Since being introduced to the market last fall, Experience Chemistry has been honored with the 2021 EdTech Breakthrough Award for "Best Science Learning Solution," the 2021 SIIA CODiE Award for "Best Advanced Science Instructional Solution," and the Tech & Learning "Best of 2020" Award.

Savvas Introduces Experience Physics, a New Program that Uses Phenomena-Based, Experiential Learning to Drive Students' Real-World Inquiry

Retrieved on: 
Tuesday, December 7, 2021

"Inquiry is central to the nature of science, and students learn best when activities are closely linked to key scientific concepts.

Key Points: 
  • "Inquiry is central to the nature of science, and students learn best when activities are closely linked to key scientific concepts.
  • That level of inquiry is enhanced with student-driven activities designed to reach every learner," said Bethlam Forsa, CEO of Savvas Learning Company. "
  • Experience Physics places students center stage as they question, investigate, and make sense of phenomena with hands-on learning experiences that connect physics to the real world."
  • This cutting-edge physics program implements an interactive instructional approach that supports student exploration of physics concepts through experiential learning of everyday phenomena.

Global HER2 Targeting Therapies Market Trends and Forecasts, 2021-2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 27, 2021

The "HER2 Targeting Therapies Market by Target Disease Indication, Type of Molecule, Type of Therapy and Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "HER2 Targeting Therapies Market by Target Disease Indication, Type of Molecule, Type of Therapy and Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
  • One of the key objectives of the report was to estimate the existing market size and the future opportunity for HER2 targeting therapies, over the next decade.
  • Based on multiple parameters, such as disease prevalence, anticipated adoption rates and likely selling price of HER2 targeting therapies, we have provided informed estimates on the evolution of the market for the period 2021-2031.
  • HER2 targeting therapies have shown to be a promising treatment option, capable of preventing tumor cells from evading immune surveillance.